{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:56:37Z","timestamp":1793642197694,"version":"4.5.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,6,12]],"date-time":"2015-06-12T00:00:00Z","timestamp":1434067200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10549-015-3465-5","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T14:06:00Z","timestamp":1434031560000},"page":"231-237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"152","author":[{"given":"Ramya","family":"Ramaswami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Daniel","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina Marie","family":"Pitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet S.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Stebbing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bindu","family":"Kalesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,6,12]]},"reference":[{"issue":"11","key":"3465_CR1","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1200\/JCO.1995.13.11.2737","volume":"13","author":"RJ Couzi","year":"1995","unstructured":"Couzi RJ, Helzisouer KJ, Fetting JH (1995) Prevalence of menopausal symptoms among women with a history of breast cancer and attitudes toward estrogen replacement therapy. J Clin Oncol 13(11):2737\u20132744","journal-title":"J Clin Oncol"},{"issue":"4","key":"3465_CR2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.hoc.2013.05.005","volume":"27","author":"D Stan","year":"2013","unstructured":"Stan D, Loprinzi CL, Ruddy KJ (2013) Breast cancer survivorship. Hematol Oncol Clin North Am 27(4):805\u2013827","journal-title":"Hematol Oncol Clin North Am"},{"issue":"3\u20134","key":"3465_CR3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0531-5565(94)90012-4","volume":"29","author":"F Kronenberg","year":"1994","unstructured":"Kronenberg F (1994) Hot flashes: phenomenology, quality of life, and search for treatment options. Exp Gerontol 29(3\u20134):319\u2013336","journal-title":"Exp Gerontol"},{"issue":"9","key":"3465_CR4","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1470-2045(05)70316-8","volume":"6","author":"M Hickey","year":"2005","unstructured":"Hickey M, Saunders CM, Stuckey BG (2005) Management of menopausal symptoms in patients with breast cancer: an evidence-based approach. Lancet oncol 6(9):687\u2013695","journal-title":"Lancet oncol"},{"issue":"3","key":"3465_CR5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.yfrne.2013.07.003","volume":"34","author":"NE Rance","year":"2013","unstructured":"Rance NE, Dacks PA, Mittleman-Smith MA et al (2013) Modulation of body temperature and LH secretion by hypothalamic KNDy (kisspeptin, neurokinin B and dynorphin) neurons: a novel hypothesis on the mechanism of hot fluhes. Front Neuroendocrinol 34(3):211\u2013227","journal-title":"Front Neuroendocrinol"},{"issue":"1","key":"3465_CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ogc.2014.09.008","volume":"42","author":"MS Krause","year":"2015","unstructured":"Krause MS, Nakajima ST (2015) Hormonal and nonhormal treatment of vasomotor symptoms. Obstet Gynecol Clin North Am 42(1):163\u2013179","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"9","key":"3465_CR7","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1789::AID-CNCR27>3.0.CO;2-#","volume":"82","author":"SK Quella","year":"1998","unstructured":"Quella SK, Loprinzi CL, Sloan JA et al (1998) Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer 82(9):1784\u20131788","journal-title":"Cancer"},{"issue":"10","key":"3465_CR8","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1200\/JCO.2006.10.6179","volume":"26","author":"JW Goodwin","year":"2008","unstructured":"Goodwin JW, Green SJ, Moinpour CM et al (2008) Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. J Clin Oncol 26(10):1650\u20131656","journal-title":"J Clin Oncol"},{"key":"3465_CR9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(04)15493-7","volume":"363","author":"L Holmberg","year":"2004","unstructured":"Holmberg L, Anderson H, For the HABITS Steering and Data Monitoring Committees (2004) HABITS (hormonal replacement therapy after breast cancer\u2013is it safe?), a randomised comparision: trial stopped. Lancet 363:453\u2013455","journal-title":"Lancet"},{"key":"3465_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/A:1008382706068","volume":"11","author":"V Stearns","year":"2000","unstructured":"Stearns V, Isaacs C, Rowland J et al (2000) A pilot trial assessing the efficacu of paroxetine hydrocholride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol 11:17\u201322","journal-title":"Ann Oncol"},{"key":"3465_CR11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1023\/B:BREA.0000010676.54597.22","volume":"83","author":"KJ Pandya","year":"2004","unstructured":"Pandya KJ, Thummala AR, Griggs JJ et al (2004) Pilot study using gabapentin for tamoxifen-induced hot flashes in women with breast cancer. Breast Cancer Res Treat 83:87\u201389","journal-title":"Breast Cancer Res Treat"},{"key":"3465_CR12","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(00)03403-6","volume":"356","author":"CL Loprinzi","year":"2000","unstructured":"Loprinzi CL, Kugler JW, Sloan JA et al (2000) Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet 356:2059\u20132063","journal-title":"Lancet"},{"issue":"2","key":"3465_CR13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/whe.14.3","volume":"10","author":"L Weber","year":"2014","unstructured":"Weber L, Thacker HL (2014) Paroxetine: a first for selective serotonin reuptake inhibitors\u2014a new use: approved for vasomotor symptoms in postmenopausal women. Womens Health (London Engl) 10(2):147\u2013154","journal-title":"Womens Health (London Engl)"},{"issue":"1","key":"3465_CR14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/jnci\/dji005","volume":"97","author":"Y Jin","year":"2005","unstructured":"Jin Y, Desta Z, Stearns V et al (2005) CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 97(1):30\u201339","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"3465_CR15","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s10549-013-2585-z","volume":"139","author":"L Binkhorst","year":"2013","unstructured":"Binkhorst L, Mathijssen RH, van Herk-Sukel MP et al (2013) Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen. Breast Cancer Res Treat 139(3):923\u2013929","journal-title":"Breast Cancer Res Treat"},{"key":"3465_CR16","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1200\/JCO.2010.33.1298","volume":"29","author":"AH Boekhout","year":"2011","unstructured":"Boekhout AH, Vincent AD, Dalesio OB et al (2011) Management of hot flashes in patients who have breast cancer with Venladaxine and Clonidine: a randomized, double-blind, placebo-controlled trial. J Clin Oncol 29:3862\u20133868","journal-title":"J Clin Oncol"},{"key":"3465_CR17","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2009.23.5150","volume":"28","author":"EM Walker","year":"2010","unstructured":"Walker EM, Rodriguez AI, Kohn B et al (2010) Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol 28:634\u2013640","journal-title":"J Clin Oncol"},{"key":"3465_CR18","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00432-013-1491-4","volume":"139","author":"N Yamaguchi","year":"2013","unstructured":"Yamaguchi N, Okajima Y, Fujii T et al (2013) The efficacy of nonestrogenic therapy to hot flashes in cancer patients under hormone manipulation therapy: a systematic review and meta-analysis. J Cancer Res Clin Oncol 139:1701\u20131707","journal-title":"J Cancer Res Clin Oncol"},{"key":"3465_CR19","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","volume":"323","author":"P Juni","year":"2001","unstructured":"Juni P, Altman DG, Egger M (2001) Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 323:42\u201346","journal-title":"BMJ"},{"key":"3465_CR20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/bmj.319.7211.670","volume":"319","author":"S Hollis","year":"1999","unstructured":"Hollis S, Campbell F (1999) What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ 319:670\u2013674","journal-title":"BMJ"},{"issue":"23","key":"3465_CR21","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1200\/JCO.2001.19.23.4280","volume":"19","author":"JA Sloan","year":"2001","unstructured":"Sloan JA, Loprinzi CL, Novotny PJ et al (2001) Methodologic lessons learned from hot flash studies. J Clin Oncol 19(23):4280\u20134290","journal-title":"J Clin Oncol"},{"issue":"6","key":"3465_CR22","doi-asserted-by":"crossref","first-page":"e38121","DOI":"10.1371\/journal.pone.0038121","volume":"7","author":"C Stradling","year":"2012","unstructured":"Stradling C, Chen YF, Russell T et al (2012) The effects of dietary intervention on HIV dyslipidaemia: a systematic review and meta-analysis. PLoS One 7(6):e38121","journal-title":"PLoS One"},{"key":"3465_CR23","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1634\/theoncologist.12-1-124","volume":"12","author":"JS Carpenter","year":"2007","unstructured":"Carpenter JS, Stomiolo AM, Johns S et al (2007) Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer. Oncologist 12:124\u2013135","journal-title":"Oncologist"},{"key":"3465_CR24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10549-008-0138-7","volume":"115","author":"C Buijs","year":"2009","unstructured":"Buijs C, Mom CH, Willemse PHB, Boezen HM et al (2009) Venlafaxine versus clonidine for the treatment of hot flashes in breast cancer patients: a double-blind, randomized cross-over study. Breast Cancer Res Treat 115:573\u2013580","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"3465_CR25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","volume":"31","author":"DR Elbourne","year":"2002","unstructured":"Elbourne DR, Altman DG, Higgins JPT et al (2002) Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 31(1):140\u2013149","journal-title":"Int J Epidemiol"},{"issue":"5","key":"3465_CR26","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/ije\/dys124","volume":"41","author":"BR Costa Da","year":"2012","unstructured":"Da Costa BR, Rutjes AWS, Johnston BC et al (2012) Methods to convert continuous outcomes into odds ratios of treatment response and numbers needed to treat: meta-epidemiological study. Int J Epidemiol 41(5):1445\u20131459","journal-title":"Int J Epidemiol"},{"issue":"7414","key":"3465_CR27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ et al (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557\u2013560","journal-title":"BMJ"},{"key":"3465_CR28","doi-asserted-by":"crossref","unstructured":"N\u00fcesch E, Trelle S, Reichenbach S et al (2010) Small study effects in meta-analyses of osteoarthritis trials: a meta-epidemiological study. BMJ 341:c3515","DOI":"10.1136\/bmj.c3515"},{"key":"3465_CR29","doi-asserted-by":"crossref","first-page":"5147","DOI":"10.1200\/JCO.2010.29.9230","volume":"28","author":"L Bordeleau","year":"2010","unstructured":"Bordeleau L, Pritchard KI, Loprinzi CL et al (2010) Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol 28:5147\u20135152","journal-title":"J Clin Oncol"},{"key":"3465_CR30","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/annonc\/mdl478","volume":"18","author":"S Loibl","year":"2007","unstructured":"Loibl S, Schwedler K, von Minckwitz G et al (2007) Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patinets\u2014a double-blind, randomized study. Ann Oncol 18:689\u2013693","journal-title":"Ann Oncol"},{"issue":"2","key":"3465_CR31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/1536867X0900900202","volume":"9","author":"RM Harbord","year":"2009","unstructured":"Harbord RM, Harris RJ, Sterne JAC (2009) Updated tests for small-study effects in meta-analyses. Stata J 9(2):197\u2013210","journal-title":"Stata J"},{"issue":"5","key":"3465_CR32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/1534735413520181","volume":"13","author":"NE Haddad","year":"2014","unstructured":"Haddad NE, Palesh O (2014) Acupuncture in the treatment of cancer-related psychological symptoms. Integr Cancer Ther 13(5):371\u2013385","journal-title":"Integr Cancer Ther"},{"key":"3465_CR33","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/0003-4819-132-10-200005160-00004","volume":"132","author":"KJ Pandya","year":"2000","unstructured":"Pandya KJ, Raubertas RF, Flynn PJ et al (2000) Oral clonidine in postmenopausal patients with breast cancer experiencing tamoxifen-induced hot flashes: a University of Rochester Cancer Center Community Clinical Oncology Program study. Ann Intern Med 132:788\u2013793","journal-title":"Ann Intern Med"},{"key":"3465_CR34","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1200\/JCO.1994.12.1.155","volume":"12","author":"RM Goldberg","year":"1994","unstructured":"Goldberg RM, Loprinzi CL, O\u2019Fallon JR et al (1994) Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol 12:155\u2013158","journal-title":"J Clin Oncol"},{"issue":"340","key":"3465_CR35","doi-asserted-by":"crossref","first-page":"c693","DOI":"10.1136\/bmj.c693","volume":"8","author":"CM Kelly","year":"2010","unstructured":"Kelly CM, Juurlink DN, Gomes T et al (2010) Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study. BMJ 8(340):c693","journal-title":"BMJ"},{"key":"3465_CR36","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1093\/jnci\/djg108","volume":"95","author":"V Stearns","year":"2003","unstructured":"Stearns V, Johnson MD, Rae JM et al (2003) Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer Inst 95:1758\u20131764","journal-title":"J Natl Cancer Inst"},{"key":"3465_CR37","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1176\/appi.ajp.2008.08040482","volume":"165","author":"NL Henry","year":"2008","unstructured":"Henry NL, Stearns V, Flockhart DA et al (2008) Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. Am J Psychiatry 165:1251\u20131255","journal-title":"Am J Psychiatry"},{"issue":"1","key":"3465_CR38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/GME.0b013e31829337a4","volume":"21","author":"KM Newton","year":"2014","unstructured":"Newton KM, Carpenter JS, Guthrie KA et al (2014) Methods for the design of vasomotor symptom trials: the menopausal strategies: finding lasting answers to symptoms and health network. Menopause 21(1):45\u201358","journal-title":"Menopause"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3465-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3465-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3465-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T14:50:03Z","timestamp":1566831003000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3465-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,12]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["3465"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3465-5","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,12]]}}}